FDA's ANDA Approvals
Executive Summary
FDA's ANDA Approvals
You may also be interested in...
Correction
Duramed's ANDA 75-809, approved July 16, contains levonorgestrel and ethinyl estradiol (1"The Pink Sheet" July 23, p. 8)
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials